These data also suggest that the mechanistic basis for the genetic associations between the PTER locus and BMI in humans may involve N-acetyltaurine. In the future, the development of potent and selective PTER inhibitors may enable pharmacological targeting of this biochemical pathway for the treatment of obesity. The gene discussed is PTER; the disease is Obesity.